Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on May 19, 2025
Hyra Holdings Approves $500M Venture Fund and IPO Roadmap to 2030 at 2025 Annual Meeting
GlobeNewswire
·
May 19, 2025
HANOI, Vietnam, May 19, 2025 (GLOBE NEWSWIRE) -- Hyra Holdings, a global technology investment group, today announced the formal approval of the Hyra Combinator Fund, a $500 million venture initiative aimed at accelerating innovation in AI, fintech, and …
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
GlobeNewswire
·
May 19, 2025
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first patient dosed in Phase 1/2 trial finds single dose of PM359 led to 58% DHR positivity by Day 15 and 66% by Day 30, well above levels …
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a …
Tyveo Exchange Partners with WAF: Igniting a New Spark in Stock and Crypto Trading
GlobeNewswire
·
May 19, 2025
New York, NY, May 19, 2025 (GLOBE NEWSWIRE) -- In the rapidly evolving global financial landscape, the convergence of traditional finance and digital assets is emerging as a defining trend. Tyveo Exchange and WAF (WealthArc Fintech) have recently announced …
Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161
GlobeNewswire
·
May 19, 2025
JUV-161 is a first-in-class muscle regenerating biologic that will address myopathies starting with Myotonic Dystrophy Type 1 JUV-161 was discovered using Juvena’s proprietary JuvNET platform, an AI and stem cell secretome-based drug discovery and …
Foresight Signs Commercialization Agreement with Global Rail Tech Provider for up to $12 Million in Revenue Starting in 2026
GlobeNewswire
·
May 19, 2025
The agreement with StreamRail, a Chinese leader in rail transit technologies, aims to enhance safety and operational efficiency for urban rail transit systems Ness Ziona, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq …
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE
GlobeNewswire
·
May 19, 2025
WEST PALM BEACH, FLORIDA, May 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center in Oneida, Tennessee, is expanding its …
Link Building Agency Serpify Launches Cutting-Edge Self-Service Link Building Platform
GlobeNewswire
·
May 19, 2025
Serpify.co a Malta-based link building agency, announced its official launch of its next-generation link building service, now available through a fully self-service platform. Built specifically for SEO professionals, agencies, and growth-focused marketers …
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
May 19, 2025
SOMERSET, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, June 1, 2025, at 6:00 p.m. CT (7:00 p.m. ET) during the …
TORRAS Redefines the iPhone Case Market with Ostand, OAir, and OFitness Series — A Fusion of Design, Durability, and Intelligent Functionality
GlobeNewswire
·
May 19, 2025
LOS ANGELES, May 19, 2025 (GLOBE NEWSWIRE) -- TORRAS, a global leader in premium mobile accessories, is once again setting new industry benchmarks with its latest iPhone case lineup, blending aesthetic elegance, user-first innovation, and intelligent …
Recludix Pharma Presents Data Demonstrating Potent Efficacy and High Selectivity of a STAT6 Inhibitor in Preclinical Asthma Model
GlobeNewswire
·
May 19, 2025
--Efficacy comparable to anti-IL4/IL13 antibody control --Achieved dose-dependent and durable target modulation in vivo without requiring degradation of STAT6 protein --Avoided broad JAK-mediated immune suppression --Data presented at the American Thoracic …
Vaidio Showcases 9th Generation Vision AI Platform at COMPUTEX 2025
GlobeNewswire
·
May 19, 2025
TAIPEI, Taiwan, May 19, 2025 (GLOBE NEWSWIRE) -- Vision AI leader Vaidio® announced today it will showcase the 9th generation of its widely-adopted AI Vision Platform at COMPUTEX 2025, taking place at the Taipei Nangang Exhibition Center from May 20 to May …
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 19, 2025
BOSTON and LONDON, May 19, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its …
Prebid.org Announces Prebid Mobile 3.0.0 – A Major Leap Forward In Making Mobile and In-App Inventory Biddable
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Prebid.org, the organization that oversees open source Prebid programmatic advertising solutions, recently announced the release of Prebid SDK 3.0.0, a major milestone for the open-source in-app bidding solution. …
Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair
GlobeNewswire
·
May 19, 2025
NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of Rachelle Jacques as Chair of its Board of Directors, …
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
GlobeNewswire
·
May 19, 2025
Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 gene therapy BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on …
Windtree Therapeutics Announces Istaroxime Presentation at European Society of Cardiology Heart Failure Conference
GlobeNewswire
·
May 19, 2025
WARRINGTON, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …
Eascra Biotech Awarded $100,000 MassVentures START Grant
GlobeNewswire
·
May 19, 2025
BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech, a nanomedicine startup, has been awarded a $100,000 Stage I SBIR Targeted Technologies (START) grant funded by the Commonwealth and managed by MassVentures. The funding is to support their work on …
Respira Therapeutics Announces Late-breaking Presentation of RT234 Phase 2b PAH Clinical Trial Results at the American Thoracic Society (ATS) 2025 International Conference
GlobeNewswire
·
May 19, 2025
PALO ALTO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Respira Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing RT234 (vardenafil inhalation powder) as the first therapy that pulmonary arterial hypertension (PAH) patients …
Rani Therapeutics Announces Research Agreement with Chugai
GlobeNewswire
·
May 19, 2025
- Research agreement is evaluating feasibility of applying Rani’s oral delivery technology to Chugai’s antibodies against undisclosed targets - SAN JOSE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “ …